Time-Dependent Diffusion MRI Reveals Hidden Microstructure of Childhood Sarcomas

Two of the most feared soft tissue tumors of childhood, rhabdomyosarcoma and extraosseous Ewing sarcoma, look frustratingly alike on conventional magnetic resonance imaging. Both appear as aggressive soft tissue masses with overlapping signal characteristics, and radiologists often cannot reliably tell them apart before a biopsy returns a verdict. That diagnostic ambiguity matters enormously, because the two cancers follow entirely different treatment pathways, and delays or errors in distinguishing them can shape a patient’s entire therapeutic trajectory. Now a team of researchers in Shanghai, working with collaborators at Siemens Healthineers, has reported a proof-of-concept study suggesting that a sophisticated variant of diffusion MRI can peer beneath the surface of these tumors and read their internal cellular architecture, offering a potential new route to noninvasive differentiation. The work, published in BMC Medical Imaging, pairs advanced imaging with an unusually rigorous form of pathological validation: every MRI slice was matched, one by one, to the corresponding histological section.

The technique at the heart of the study is called time-dependent diffusion MRI, abbreviated T_d-dMRI. Its underlying logic is elegant. In standard diffusion-weighted imaging, water molecules inside tissue diffuse randomly, and their movement is hindered by cell membranes and other obstacles. The apparent diffusion coefficient, or ADC, summarizes this restriction in a single number, but that number conflates many different microstructural influences. Time-dependent diffusion MRI changes the experimental geometry instead. Using pulsed gradient spin-echo sequences, the diffusion-weighting gradients act over relatively long times, allowing water to wander across substantial distances and probe large-scale tissue structure. Oscillating gradient spin-echo sequences, by contrast, reverse the gradient direction rapidly, effectively confining the measurement to very short diffusion times during which water molecules can only explore their immediate cellular neighborhood. By comparing diffusivity measured at long and short diffusion times, the method gains sensitivity to features such as cell size, cell density, and the volume fraction occupied by cells, which conventional ADC cannot disentangle.

To translate these raw measurements into biologically meaningful numbers, the researchers applied a model known as IMPULSED. This analytical framework treats tissue as a collection of impermeable cells embedded in an extracellular space and fits the diffusion signal acquired at multiple frequencies to estimate specific microstructural parameters. Four quantities emerge from the fit: the extracellular diffusivity, which reflects how freely water moves outside cells; the intracellular volume fraction, which captures the proportion of the tissue volume packed inside cell membranes; an estimate of cellularity; and an estimate of mean cell diameter. Each of these parameters has a direct pathological counterpart that a pathologist can measure under the microscope, which is precisely what makes the approach so attractive for radiologic-pathologic correlation.

The experimental system consisted of xenograft tumors grown in nude mice. The team implanted two human-derived cell lines: RD, which produces rhabdomyosarcoma tumors, and A673, which produces extraosseous Ewing sarcoma tumors. Thirty-three rhabdomyosarcoma xenografts and thirty Ewing sarcoma xenografts underwent the time-dependent diffusion protocol. Two independent readers derived the microstructural parameters from whole-tumor volumes, allowing the study to assess measurement reproducibility as well as diagnostic performance. The choice of xenograft models is an important caveat that the authors themselves emphasize: these are controlled, single-cell-line systems, which are ideal for establishing proof of concept but do not capture the heterogeneity of human tumors.

The results revealed striking and statistically robust differences between the two tumor types. Rhabdomyosarcoma xenografts showed significantly lower cellularity than Ewing sarcoma xenografts, with values of 2.88 versus 4.34 per micrometer, and a lower intracellular volume fraction of 0.44 versus 0.58. The rhabdomyosarcoma cells were also larger, with an estimated mean diameter of 18.59 micrometers compared with 16.56 micrometers for the Ewing sarcoma cells, and water diffused more freely in their extracellular space, at 0.82 versus 0.69 square micrometers per millisecond. Perhaps most intriguing was the behavior of the ADC across diffusion times. When the sequence shifted from the long-diffusion-time pulsed gradient to the rapidly oscillating 50-hertz gradient, the relative ADC change was 85.5 percent in rhabdomyosarcoma but 179.8 percent in Ewing sarcoma. All of these differences reached statistical significance at P less than 0.01. In physical terms, the Ewing sarcoma tumors, being more densely packed with smaller cells, restricted water far more severely at short diffusion times, producing a much larger swing in measured diffusivity.

Diagnostic performance was assessed with receiver operating characteristic analysis, which quantifies how well a parameter separates two classes. Time-dependent diffusion MRI-derived cellularity achieved an area under the curve of 0.92, while the ADC measured with the 50-hertz oscillating gradient achieved 0.91. A DeLong test comparing the two curves found no statistically significant difference, with P equal to 0.67, indicating that the model-derived cellularity estimate and the simpler oscillating-gradient ADC performed comparably in this setting. That equivalence is worth noting: the model-free ADC at a single oscillating frequency captured nearly all of the discriminative power, which could simplify clinical implementation if the finding holds in human tissue.

The methodological centerpiece of the study, and what distinguishes it from much of the existing diffusion MRI literature, is the slice-by-slice radiologic-pathologic correlation. Rather than comparing whole-tumor imaging averages with whole-tumor histology scores, the researchers registered hematoxylin and eosin stained sections to the corresponding MRI slices, aligning each microscopic field with its radiologic counterpart. This co-registration allowed the team to test whether the in vivo imaging parameters genuinely tracked microscopic reality at the same anatomical location. The answer was affirmative across the board: all of the time-dependent diffusion MRI parameters showed significant associations with the matched histological features. The strongest relationship linked in vivo MRI-derived cellularity with ex vivo pathological nuclear density, yielding a Spearman correlation coefficient of 0.784 with P less than 0.001. In other words, the scanner was not merely producing numbers that differed between tumor types; it was reproducing, noninvasively, what the pathologist counted under the lens.

Why does this matter beyond the xenograft laboratory? Soft tissue sarcomas encompass dozens of distinct entities with divergent biology, and rhabdomyosarcoma and extraosseous Ewing sarcoma are among the most clinically consequential in young patients. Rhabdomyosarcoma, arising from skeletal muscle lineage, and Ewing sarcoma, driven in most cases by characteristic gene fusions, require different chemotherapy regimens, different local therapy strategies, and different surveillance plans. Current multiparametric MRI, combining T1-weighted, T2-weighted, and conventional diffusion sequences, provides limited traction because the tumors share so many gross features. A validated microstructural imaging biomarker could, in principle, sharpen pre-biopsy differential diagnosis, guide the placement of biopsy needles toward the most diagnostically informative tumor regions, and potentially serve as a noninvasive marker of treatment response, since effective therapy should alter cellularity and cell size in measurable ways.

The authors are careful, appropriately, to frame the study as a proof of concept rather than a clinical result. The findings are model-specific, derived from two xenograft lines in mice, and do not yet establish that the technique can differentiate human rhabdomyosarcoma from human Ewing sarcoma in patients. Human tumors are heterogeneous mosaics of divergent clones, stromal cells, necrotic regions, and edema, and their microstructural signatures will be far messier than those of pure cell-line xenografts. The IMPULSED model also rests on assumptions, such as impermeable cell membranes, that may be violated in aggressive tumors with leaky vasculature and dying cells. Validation across additional biological models and, crucially, human cohorts is required before any clinical translation. The imaging hardware is another consideration: oscillating gradient sequences demand specialized gradient hardware and acquisition protocols, although the involvement of Siemens Healthineers researchers suggests that implementation on clinical scanners is a realistic goal.

Even with those caveats, the study represents a meaningful step toward a long-sought goal in oncologic imaging: turning the MRI scanner into a virtual microscope. The combination of time-dependent diffusion encoding, biophysical modeling, and rigorous slice-matched histologic validation offers a template for how microstructural imaging biomarkers should be developed and tested. If subsequent studies in human patients confirm that cellularity and related parameters can be measured reliably in vivo and correlate with pathology at the level of individual tissue slices, the implications could extend well beyond sarcomas, potentially informing the characterization of brain tumors, breast lesions, and prostate cancer, where microstructural imaging is already under intense investigation. For now, the Shanghai team has demonstrated that the water molecules diffusing through a living tumor carry a readable record of its cellular architecture, and that record can be checked, slice by slice, against the truth that only the pathologist has traditionally been able to see.

Subject of Research: Time-dependent diffusion MRI microstructural characterization of rhabdomyosarcoma and extraosseous Ewing sarcoma xenografts with radiologic-pathologic correlation

Article Title: Time-dependent diffusion MRI for microstructural characterisation of rhabdomyosarcoma and extraosseous Ewing sarcoma xenografts: a proof-of-concept study with slice-by-slice radiologic-pathologic correlation

Article References: Long, H., Liang, H., Hu, X., Yuan, Z., Liu, M., Feiweier, T., Tao, H., Li, X., & Chen, S. (2026). Time-dependent diffusion MRI for microstructural characterisation of rhabdomyosarcoma and extraosseous Ewing sarcoma xenografts: a proof-of-concept study with slice-by-slice radiologic-pathologic correlation. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02799-x

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02799-x

Keywords: diffusion MRI, rhabdomyosarcoma, Ewing sarcoma, xenograft, cellularity, IMPULSED model, OGSE, PGSE, ADC, radiologic-pathologic correlation, soft tissue sarcoma, cancer imaging